Align Technology | ALGN - Ebit

Aktienkurs
173.14
Täglich Wechseln
-1.39 -0.80%
Monatlich
-0.96%
Jährlich
5.48%
Q2 Prognose
168.41




Ebit Veränderung Datum
3M USD 1.21B 394M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Cardinal Health USD 763M 9M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
CVS Health USD 2.11B 836M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Henry Schein USD 186M 12M 2025-12
Idexx Laboratories USD 315.6M 39.24M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Masimo USD 83.9M 200K 2025-12
McKesson USD 1.66B 159M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Stryker USD 1.97B 609M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veeva Systems USD 245.88M 5.02M 2025-12
Waters USD 270.52M 78.4M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12
Zoetis USD 835M 140M 2025-12